Macquarie Group’s Guardant Health GH Stock Holding History

Macquarie Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.2K	Buy	+308	New	+$33.5K	﹤0.01%	852
2025 Q4	–	Sell	-328,049	Closed	-$20.5M	–	1103
2025 Q3	$20.5M	Buy	328,049 +204,590	+166%	+$11.1M	0.02%	655
2025 Q2	$6.42M	Sell	123,459 -65,781	-35%	-$2.94M	0.01%	920
2025 Q1	$8.06M	Buy	+189,240	New	+$8.16M	0.01%	855
2022 Q4	–	Sell	-1,084	Closed	-$116K	–	1901
2022 Q3	$116K	Sell	1,084 -1,070	-50%	-$54.9K	﹤0.01%	1728
2022 Q2	$87K	Hold	2,154	–	–	﹤0.01%	1901
2022 Q1	$143K	Hold	2,154	–	–	﹤0.01%	1867
2021 Q4	$215K	Sell	2,154 -1,032,758	-100%	-$107M	﹤0.01%	1748
2021 Q3	$129M	Buy	1,034,912 +213,241	+26%	+$25.3M	0.11%	245
2021 Q2	$102M	Buy	821,671 +819,274	+34,179%	+$110M	0.08%	298
2021 Q1	$366K	Sell	2,397 -310	-11%	-$46.9K	﹤0.01%	1578
2020 Q4	$349K	Buy	2,707 +600	+28%	+$69K	﹤0.01%	1526
2020 Q3	$236K	Hold	2,107	–	–	﹤0.01%	1577
2020 Q2	$171K	Buy	+2,107	New	+$170K	﹤0.01%	1594

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Macquarie Group's GH Position: Q2 2026 in Review

Macquarie Group opened a new position in Guardant Health (GH) in Q2 2026: 308 shares worth $46.2K. The stake represents ﹤0.01% of the portfolio and ranks #852 among its holdings. This is a return to the name: Macquarie Group previously reported a position in GH as recently as Q3 2025.

Macquarie Group first reported a position in GH in Q2 2020 and has held it in 14 quarters since. The position peaked at $129M in Q3 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Macquarie Group held 308 shares of Guardant Health worth $46.2K as of Q2 2026.
Guardant Health was a new Macquarie Group position in Q2 2026.
Guardant Health made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #852 holding.
Macquarie Group first reported a position in Guardant Health in Q2 2020 and has held it in 14 quarters since.
Macquarie Group's Guardant Health position peaked at $129M in Q3 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.